CS logo
small CS logo
Impact Clinical Trials

Las Vegas, Nevada, United States
Health in Las Vegas, Nevada
1001 S Rancho Dr, Las Vegas, NV 89106

About Impact Clinical Trials


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Gilead Sciences
5
Pfizer
3
Rhythm Pharmaceuticals, Inc.
2
Sucampo Pharma Americas, LLC
2
Aderans Research Institute
1
Alexion
1
Allergan
1
BioCryst Pharmaceuticals
1
Dr. Reddy's Laboratories Limited
1
Eli Lilly and Company
1
Engage Therapeutics, Inc.
1
Total Rows: 17

Clinical Trials at Impact Clinical Trials


During the past decade, Impact Clinical Trials conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 12 clinical trials were completed, i.e. on average, 150% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 6 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years33111122111111220022Started TrialsCompleted Trails2015201620172018201901234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Effectiveness and Safety of Ramipril in the Treatment of Hypertension in Children and Adolescents
2006-10-01
2007-11-01
Terminated
422
DORADO-AC-EX - A Long-Term Safety Extension Study to the Phase 3 DORADOC-AC Study (Protocol DAR-312) of Darusentan in Resistant Hypertension
2007-05-01
2010-05-01
Terminated
661
DORADO-AC - Optimized Doses of Darusentan as Compared to an Active Control in Resistant Hypertension
2006-09-01
2009-08-01
Completed
849
Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone
2007-08-01
2009-03-01
Completed
439
Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone
2007-12-01
2009-09-01
Completed
439
A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With Uncomplicated Acute Influenza
2008-07-01
2009-10-01
Completed
405
A Study of Topical Danazol for the Treatment of Pain Associated With Fibrocystic Breast Disease
2007-01-01
2009-06-01
Completed
60
Safety, Tolerability and Antiviral Activity of ACH-0141625 or Placebo in Combination With Peginterferon and Ribavirin in HCV Positive Subjects
2010-09-01
2013-04-01
Completed
122

Rows per page:

1–25 of 25

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Impact Clinical Trials" #1 sponsor was "Gilead Sciences" with 5 trials, followed by "Pfizer" with 3 trials sponsored, "Rhythm Pharmaceuticals, Inc." with 2 trials sponsored, "Sucampo Pharma Americas, LLC" with 2 trials sponsored and "Aderans Research Institute" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Impact Clinical Trials" #1 collaborator was "Accelovance" with 1 trials as a collaborator, "Health Decisions" with 1 trials as a collaborator, "Integrium" with 1 trials as a collaborator, "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator and "Syneos Health" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.
Created with Highcharts 11.1.0Top Leading SponsorsGilead Sciences: 5Gilead Sciences: 5Pfizer: 3Pfizer: 3Rhythm Pharmaceuticals, Inc.: 2Rhythm Pharmaceuticals, Inc.: 2Sucampo PharmaAmericas, LLC: 2Sucampo PharmaAmericas, LLC: 2Aderans Research Institute: 1Aderans Research Institute: 1Alexion: 1Alexion: 1Allergan: 1Allergan: 1BioCryst Pharmaceuticals: 1BioCryst Pharmaceuticals: 1Dr. Reddy'sLaboratories Limited: 1Dr. Reddy'sLaboratories Limited: 1Eli Lilly and Company: 1Eli Lilly and Company: 1

Created with Highcharts 11.1.0Top CollaboratorsAccelovance: 1Accelovance: 1Health Decisions: 1Health Decisions: 1Integrium: 1Integrium: 1SucampoPharmaceuticals, Inc.: 1SucampoPharmaceuticals, Inc.: 1Syneos Health: 1Syneos Health: 1

Clinical Trials Conditions at Impact Clinical Trials


According to Clinical.Site data, the most researched conditions in "Impact Clinical Trials" are "Hypertension" (3 trials), "Hepatitis C" (2 trials), "Opioid-Induced Bowel Dysfunction" (2 trials), "Acute, Uncomplicated Human Influenza" (1 trials) and "Androgenetic Alopecia" (1 trials). Many other conditions were trialed in "Impact Clinical Trials" in a lesser frequency.

Clinical Trials Intervention Types at Impact Clinical Trials


Most popular intervention types in "Impact Clinical Trials" are "Drug" (21 trials), "Biological" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Darusentan" (2 trials), "Guanfacine" (2 trials), "ACH-0141625 (Sovaprevir)" (1 trials) and "Abametapir Lotion 0.74% w/w" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Impact Clinical Trials


The vast majority of trials in "Impact Clinical Trials" are 22 trials for "All" genders and 3 trials for "Female" genders.

Clinical Trials Status at Impact Clinical Trials


Currently, there are NaN active trials in "Impact Clinical Trials". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in Impact Clinical Trials, undefined suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Impact Clinical Trials, 1 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 10Phase 3: 10Phase 2: 9Phase 2: 9Phase 4: 3Phase 4: 3Not Applicable: 1Not Applicable: 1Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 22Completed: 22Terminated: 3Terminated: 3